Early and long-term mortality of the clinical subtypes of myocarditis

M Kodama1, H Oda, M Okabe

  • 1Division of Cardiology, Niigata Graduate School of Medicine & Dental Science, Japan. kodamama@med.niigata-u.ac.jp

Insights

Myocarditis has high early mortality across subtypes, but long-term survival is favorable if patients overcome the acute phase, except for the chronic latent form. This study clarifies myocarditis prognosis and classification challenges.

Area of Science:

  • Cardiology
  • Pathology

Background:

  • Myocarditis frequency and prognosis are uncertain.
  • Clinical classification of myocarditis is controversial.

Purpose of the Study:

  • To investigate the frequency, clinical classification, and prognosis of myocarditis.
  • To analyze early and long-term mortality rates for different myocarditis subtypes.

Main Methods:

  • Retrospective analysis of 71 adult patients with suspected myocarditis from 1985-2000 across 11 centers.
  • Histological confirmation of myocarditis in 48 cases, categorized into lymphocytic, giant cell, and eosinophilic types.
  • Classification of myocarditis into acute (common/fulminant) and chronic (persistent/recurrent/latent) subtypes based on onset and management.

Main Results:

  • Histology confirmed 48 cases: 41 lymphocytic, 6 giant cell, 1 eosinophilic.
  • Early mortality rates varied by subtype, with acute fulminant (43%) and chronic recurrent (50%) being highest.
  • Overall early mortality was 38%, but long-term prognosis was favorable for survivors, with only 4 late deaths, primarily in the chronic latent form.

Conclusions:

  • Myocarditis exhibits high early mortality irrespective of subtype.
  • Patients surviving the acute phase generally have a favorable long-term prognosis.
  • The chronic latent form of myocarditis presents an exception to the favorable long-term outlook.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...